PharVision Advisers’s Advanced Micro Devices AMD Stock Holding History

PharVision Advisers’s Portfolio AMD Stock Details AMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,116	Closed	-$239K	–	120
2025 Q4	$239K	Buy	+1,116	New	+$251K	0.12%	427

Other funds holding AMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

PharVision Advisers's AMD Position: Q1 2026 in Review

PharVision Advisers sold out of Advanced Micro Devices (AMD) in Q1 2026, closing a stake of 1,116 shares — an estimated $239K sold.

PharVision Advisers first reported a position in AMD in Q4 2025 and held it in 1 quarter. The position peaked at $239K in Q4 2025. 3,166 funds tracked by Wall St. Rank hold AMD as of Q1 2026.

PharVision Advisers reported no remaining Advanced Micro Devices position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,116 Advanced Micro Devices shares in Q1 2026, an estimated $239K.
PharVision Advisers first reported a position in Advanced Micro Devices in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Advanced Micro Devices position peaked at $239K in Q4 2025.
3,166 funds tracked by Wall St. Rank held Advanced Micro Devices as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.